focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS4 Cap. Regulatory News (SFOR)

Share Price Information for S4 Cap. (SFOR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 58.35
Bid: 58.20
Ask: 59.15
Change: -1.15 (-1.93%)
Spread: 0.95 (1.632%)
Open: 60.00
High: 60.00
Low: 57.25
Prev. Close: 59.50
SFOR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

31 Aug 2017 07:00

RNS Number : 3685P
Derriston Capital PLC
31 August 2017
 

 

DERRISTON CAPITAL PLC

("Derriston" or the "Company")

 

Interim Report for the period ended 30 June 2017

Derriston Capital (Derr) announces its unaudited interim financial results for the period ended 30 June 2017.

 

Period highlights

 

· On 29 December 2016, the Company was admitted to the standard segment of the Official List and to trading on the London Stock Exchange's Main Market 

· Raised £2.3 million cash (gross) through the listing of 25,000,000 new ordinary shares

 

Post period highlight

 

· Change in strategy from investing in medtech to seeking acquisitions within all technology and other high growth sectors.

 

 

Harry Hyman, Chairman of Derriston said: "Admission to the standard list has given Derriston the profile, funding and liquid equity to consider a number of acquisitions.

 

"Given the large number of exciting opportunities we are analysing, the board has decided to widen the scope of Derriston's investment criteria and look at acquisitions within all technology and other high growth sectors."

 

 

For information please contact:

 

Walbrook PR Ltd

Tel: 020 7933 8780

Paul McManus

 

 

 

CHAIRMAN'S STATEMENT FOR THE PERIOD ENDED 30 JUNE 2017

 

 

Introduction

 

I am pleased to present the unaudited interim results for the period ended 30 June 2017. Derriston floated on to the standard listing of the official list on the London Stock Exchange on 29 December 2016. The Company was created to undertake an acquisition within the medical technology industry.

 

During this period, Derriston recorded a loss of £140,176, the vast majority relating to the formation of the Company and its admission to the standard list. Since float, the Company has lost £7,273. Cash assets at period end were nearly £2.2 million and it has no debts.

 

 

Outlook

 

Given the large number of exciting opportunities we are analysing, the board has decided to widen the scope of Derriston's investment criteria and look at acquisitions within all technology and other high growth sectors

 

I believe this change in strategy can create significant shareholder value and I look forward to updating the market when further progress is made.

 

 

 

Harry Hyman

Chairman

 

31 August 2017

 

 

 

INTERIM STATEMENT OF COMPREHENSIVE INCOME

FOR THE PERIOD FROM 14 NOVEMBER 2016 TO 30 JUNE 2017

 

 

 

 

Period ended

 

 

30.06.2017

 

(Unaudited)

 

Notes

£

 

 

 

Revenue

2

-

 

 

-------------------

Gross profit

 

-

 

 

 

General & administrative expenses

 

(144,403)

 

 

-------------------

Loss from operations before interest

 

(144,403)

 

 

 

Interest income

 

4,192

 

 

--------------------

Loss before tax

 

(140,211)

 

 

 

Tax

 

-

 

 

---------------------

Retained Loss after tax for the period

 

(140,211)

 

 

===========

 

 

 

Retained loss attributable to:

 

 

Owners of the company

 

(140,211)

 

 

---------------------

Loss for period

 

(140,211)

 

 

===========

Total comprehensive loss attributable to:

 

 

Owners of the company

 

(140,211)

 

 

---------------------

Total comprehensive loss for the period

 

(140,211)

 

 

===========

 

 

 

Loss per share

 

 

Basic and diluted

3

(0.68p)

 

 

===========

 

 

INTERIM STATEMENT OF FINANCIAL POSITION

AS AT 30 JUNE 2017

 

 

 

 

As at

 

 

 30.06.2017

 

 

(Unaudited)

 

Notes

£

ASSETS

 

 

 

 

 

Current assets

 

 

Cash and cash equivalents

 

2,193,961

 

 

-----------------------

TOTAL ASSETS

 

2,193,961

 

 

============

 

 

 

 

 

 

EQUITY

 

 

Share capital

4

625,000

Share premium reserve

 

1,706,250

Retained loss

 

(140,211)

 

 

------------------------

TOTAL EQUITY

 

2,191,039

 

 

============

 

 

 

CURRENT LIABILITIES

 

 

Trade and other payables

 

2,922

 

 

------------------------

TOTAL EQUITY AND LIABILITIES

 

2,193,961

 

 

============

 

 

 

 

 

 

 

 

 

INTERIM STATEMENT OF CHANGES IN EQUITY

FOR THE PERIOD FROM 14 NOVEMBER 2016 TO 30 JUNE 2017

 

 

 

 

 

 

 

Share

 

 

 

Share

premium

Retained

Total

 

capital

account

loss

equity

 

£

£

£

£

 

 

 

 

 

Balance at 14 November 2016

-

-

-

-

Loss for the period

-

-

(140,211)

(140,211)

 

 

 

 

 

Total comprehensive income for the period

-

-

(140,211)

(140,211)

Share capital issued (net of transaction costs)

625,000

1,706,250

-

2,331,250

Balance at 30 June 2017

625,000

1,706,250

(140,211)

2,191,039

 

 

 

 

 

 

 

INTERIM STATEMENT OF CASH FLOW

FOR THE PERIOD FROM 14 NOVEMBER 2016 TO 30 JUNE 2017

 

 

Period ended

 

30.06.2017

 

£

 

(Unaudited)

Cash flow from operating activities

 

Loss for the period

(140,211)

 

------------------------

Operating cash flows before movements in working capital

(140,211)

Interest income

(4,192)

Increase in receivables

-

Increase in payables

2,922

 

-----------------------

Net cash flow from operating activities

(141,481)

 

 

Cash flow from investing activities

 

Interest income

4,192

 

------------------------

Net cash flow from investing activities

4,192

 

 

Cash flow from financing activities

 

Net proceeds from issue of share capital

2,331,250

 

------------------------

Net cash flow from financing activities

2,331,250

 

 

Net cash inflow for the period

2,193,961

 

------------------------

 

 

Cash and cash equivalents at start of period

-

 

------------------------

Cash and cash equivalents at end of period

2,193,961

 

============

 

 

 

 

 

NOTES TO THE UNAUDITED INTERIM REPORT

FOR THE PERIOD ENDED 30 JUNE 2017

 

1. BASIS OF PREPARATION

 

The interim financial statements have been prepared on a going concern basis and in accordance with the recognition and measurement principles of International Financial Reporting Standards adopted for use in the European Union ("IFRS").

 

The interim financial statements for the period ended 30 June 2017 have not been audited and do not constitute statutory accounts within the meaning of Section 434 of the Companies Act 2006. 

 

This Interim Financial Report was approved by the Board of Directors on 30 August 2017.

 

Statement of compliance

 

These condensed consolidated interim financial statements have been prepared in accordance with International Accounting Standard ('IAS') 34 - Interim Financial Reporting as adopted by the European Union. Accordingly the interim financial statements do not include all of the information or disclosures required in the annual financial statements. 

 

2. TURNOVER AND SEGMENTAL ANALYSIS

 

All of the Company's activity and income and expenses in the period ended 30 June 2017 were incurred in the United Kingdom, and relate to Derriston's ongoing investment activities.

 

3. LOSS PER SHARE

 

The calculation of the basis and diluted earnings per share is based on the following data:

 

Period to

 

30.6.2017

Earnings

 

Earnings for the purposes of basic earnings per share net loss for the

 

period attributable to equity holders of the company

(140,211)

Number of shares

 

Weighted average number of ordinary shares in issue

20,529,476

 

The denominator for the purpose of calculating the basic earnings per share has been adjusted to reflect all capital raisings.

 

4.

SHARE CAPITAL

Number of

Nominal value

Premium

 

 

 

shares

£

£

 

 

 

a) Issued and Fully Paid:

 

 

 

 

 

 

 

 

 

 

 

 

 

14 November 2016

2,250,000

£56,250

-

 

 

 

29 December 2016

22,750,000

£568,750

£1,706,250

 

 

 

 

--------------------------

-------------------------

------------------------

 

 

 

As at 30 June 2017

25,000,000

£625,000

£1,706,250

 

 

 

 

==============

=============

=============

 

 

 

 The nominal value of the shares is £0.025

 

 

 

 

 

5. AVAILABILITY OF INTERIM RESULTS

 

Copies of the Interim Results for the period to 30 June 2017 are available from the Company's registered address and will be available on the Company's website, later today.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR SDAESSFWSEIA
Date   Source Headline
20th Jan 20217:00 amRNSStaud Studios to merge with MediaMonks
15th Jan 20214:35 pmRNSDirector/PDMR Shareholding and TR-1s
15th Jan 202111:41 amRNSDirector/PDMR Shareholding
12th Jan 20217:00 amRNSIssue of Shares
11th Jan 20217:00 amRNSTOMORROW to merge with MediaMonks
6th Jan 20217:00 amRNSBlock listing six monthly return
6th Jan 20217:00 amRNSDirector/PDMR Shareholding
5th Jan 20217:00 amRNSIssue of Shares
4th Jan 20217:00 amRNSPost-Brexit Combinations and Trading Statement
31st Dec 20207:00 amRNSTotal Voting Rights
1st Dec 202010:30 amRNSTotal Voting Rights
23rd Nov 20206:04 pmRNSMondelez International press release
12th Nov 20207:00 amRNSIssue of Shares
9th Nov 20207:00 amRNSThird Quarter Trading Update
3rd Nov 202012:01 pmRNSTotal Voting Rights
3rd Nov 202010:52 amRNSHolding(s) in Company
3rd Nov 20207:00 amRNSIssue of Shares
14th Oct 20202:08 pmRNSDirector/PDMR Shareholding
2nd Oct 20206:20 pmRNSIssue of Shares
30th Sep 20202:30 pmRNSTotal Voting Rights
29th Sep 20207:00 amRNSIssue of Shares
14th Sep 20208:45 amRNSIssue of Shares
10th Sep 20203:29 pmRNSBMW press release
10th Sep 20207:01 amRNSIssue of Shares
10th Sep 20207:00 amRNSDare.Win to merge with MediaMonks
9th Sep 20207:00 amRNSResults for the six months ended 30 June
3rd Sep 20207:00 amRNSIssue of Shares
1st Sep 202011:22 amRNSTotal Voting Rights
27th Aug 20207:00 amRNSBrightblue to merge with MightyHive
26th Aug 20201:19 pmRNSHolding(s) in Company
31st Jul 20207:00 amRNSIssue of Shares
31st Jul 20207:00 amRNSTotal Voting Rights
29th Jul 20204:30 pmRNSOrca Pacific to merge with MightyHive
23rd Jul 20204:58 pmRNSHolding(s) in Company
20th Jul 20203:29 pmRNSDirector/PDMR Shareholding
17th Jul 20207:00 amRNSIssue of Shares
16th Jul 20207:11 amRNSResults of Fundraising
15th Jul 20205:09 pmRNSProposed Fundraising
15th Jul 20205:05 pmRNSTrading Update
13th Jul 20207:00 amRNSNotice of Results and Capital Markets Day
6th Jul 202010:53 amRNSHolding(s) in Company
6th Jul 202010:51 amRNSHolding(s) in Company
30th Jun 20207:00 amRNSTransaction and Board Appointment
30th Jun 20207:00 amRNSTotal voting rights and Block Listing 6m Return
24th Jun 20208:00 amRNSIssue of Shares
11th Jun 20207:00 amRNSIssue of Shares
8th Jun 20205:41 pmRNSResults of Annual General Meeting
8th Jun 20207:00 amRNSAGM Statement
29th May 202010:21 amRNSTotal Voting Rights
26th May 20207:00 amRNSDigodat to merge with MightyHive

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.